AMNIOBURN
Live / Registered — Registered (as of 01 Nov 2022)
What this means for you
Registered since 01 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90526381
- Registration number
- 6890428
- Mark type
- Stylized text
- Filed
- 12 Feb 2021
- Published for opposition
- 12 Oct 2021
- Registered
- 01 Nov 2022
- Attorney of record
- Marcy L. Sperry, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Biologic drugs for treating inflammation and pain using regenerative tissue components; human biological amniotic membrane tissue intended for subsequent implantation
Owner
- MiMedx Group, Inc., Marietta, GA, US
- MiMedx Group, Inc., Marietta, GA, US
- MiMedx Group, Inc., Marietta, GA, US
Prosecution history
- 01 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 28 Sept 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Sept 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Sept 2022 — ASSIGNED TO EXAMINER
- 27 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jun 2022 — USE AMENDMENT FILED
- 27 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 07 Dec 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Oct 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Oct 2021 — PUBLISHED FOR OPPOSITION
- 22 Sept 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Sept 2021 — ASSIGNED TO EXAMINER